In both GSD l a and I b, hepatic defects prevent the conversion of glucose-6-phosphate to glucose resulting in hypoglycemia during fasting ( 1, 2) . In GSD la, the enzyme glucose-6-phosphatase is defective ( I , 2), whereas in G S D I b, the glucose-6-phosphate translocase is affected (3) (4) (5) . The clinical features of GSD I b are similar to those of GSD la with the exception that patients with GSD I b are often neutropenic and suffer from recurrent bacterial infections suggesting an impairment in their immune system (6-1 1 ) .
--,-
There is evidence of functional defects in the phagocytic cells from GSD Ib patients that limit their ability to destroy invading microorganisms. Multiple functional abnormalities have been identified including chemotaxis, bactericidal activity, respiratory burst activity, and glucose transport (12) (13) (14) (15) (16) (17) (18) . We previously demonstrated that the defect in respiratory burst activity was associated with impaired calcium mobilization and decreased intracellular calcium stores (18, 19) . It is not apparent whether these phagocytic cell dysfunctions are a result of multiple defects or of a more fundamental membrane defect.
Previous studies on the rcspiratory burst of monocytes from GSD Ib patients have focused exclusively on circulating cells ( 15. 18) : however, it1 vivo, the circulating monocytes migrate into tissue, where they adhere and over time differentiate into mature macrophages (20) . Both cell adherence and differentiation modulate the kinetics of the 02-generation ( 2 . It is not known whether GSD Ib macrophages also have defective respiratory burst activity.
Macrophages can be functionally modified it1 tdtro through exposure to cytokines. such as IFN-y. IFN-y is a potent macrophage activator that is secreted by T cells. Among its varied effects, it1 vitro incubation with IFN-y has been shown to stimulate cell differentiation and enhance rcspiratory burst activity in MDM (25) (26) (27) . In addition, IFN-y has been used it1 vivo to improve respiratory burst activity in patients with chronic granulomatous disease, leprosy, and HIV infection (28-3 1) .
The purposes of this study were 1 ) to determine whether the respiratory burst activity in macrophages was also defective in GSD Ib and 2) to establish the efficacy of IFN-y treatment on the depressed respiratory burst in GSD I b. Similar to circulating phagocytic cells. MDM from GSD Ib patients had a selective defect in 0 2 -generation in response to the ligands fMet-Leu-Phe and Con A. Accordingly, GSD Ib phagocytic cells have an intrinsic defect in respiratory burst activity that is not dependent on cellular environment. However, unlike the peripheral blood phagocytic cells, MDM from G S D Ib patients d o not have a depressed respiratory burst in response to PMA. Therefore, the defect in GSD I b respiratory burst activity in response to PMA stimulation is corrected after i n vitro culture and cell differentiation. I n vifro culture of MDM from G S D Ib patients with IFN-y enhanced 0 2 -production to levels similar to controls in response to either Wet-Leu-Phe or Con A. Moreover, a comparison of the cell cultures revealed that GSD I b MDM showed morphologic differences in comparison to control cells that were ameliorated by IFN-y treatment. Thus, MDM from GSD Ib patients have a selective defect in respiratory burst activity to ligand stimulation that can be corrected in vitro with IFN-y.
MATERIALS AND METHODS
Study population. The study population consisted of five unrelated GSD Ib patients: two men aged 28 and 24 y and three girls aged 4, 9, and 13 y. Written permission was obtained from patients or their parents for all blood samples in accordance with policies of the Institutional Review Board at the Children's Hospital of Philadelphia. Control blood samples were obtained from healthy adults routinely used as donors in our laboratory.
Monocyte isolation and cliltzire of AfDAf. Monocytes were isolated from heparinized venous blood (1 x lo4 U/L) and cultured as previously described (32) . Mononuclear cells, separated from whole blood by Ficoll-Hypaque centrifugation, were suspended in Dulbecco's Modified Eagle Media (DMEM; GIBCO Laboratories, Grand Island, NY). The cell suspension was plated onto gelatin-coated tissue culture flasks and incubated at 37°C for 45 min in 5% C02. Nonadherent cells were removed by several washings. Adherent monocytes were detached by incubation with 5 mM EDTA in DMEM with 10% horse serum (HS; GIBCO Laboratories), washed, and resuspended in DMEM supplemented with 10% FCS (Hyclone Laboratories, Logan,
and streptomycin (100 mg/L). Cells were plated at 2.0-3.5 x 10' cells/polylysine-coated glass coverslip/well in 24-well tissue culture plates. After 24 h of incubation at 37°C in 5% COz, nonadherent cells were removed by aspiration and fresh medium was added in the presence or absence of 1 x lo5 U/L of recombinant human IFN-y (1 x lo5 U/L = 100U/mL) (Hoffman-La Roche, Nutley, NJ). Cell cultures were maintained at 37°C in 5% C 0 2 for 9 d.
02-generation. The generation of 0 2 -by MDM was measured on the 9th d of culture in the well plate as superoxide dismutaseinhibitable cytochrome c reduction by endpoint analysis (33) . DNA assay. DNA from MDM cultures was assayed according to a procedure adapted from West et a/. (34) . Ten mM EDTA, pH 12.3, were added to each well and incubated for 90 min at 37'C. After the plates were cooled on ice, the pH was lowered to pH 7.0 with 1 M KH2P04. The supernatants were incubated for 20 min with 9.0 x lo-' M Hoescht no. 33258 (bisBenzimide; Sigma Chemical Co., St. Louis, MO) and diluted in 100 mM NaC1-I0 mM Tris, pH 7.0. Fluorescence was measured using an excitation wavelength of 350 nm and an emission wavelength of 455 nm. A standard curve from 0.3 1 to 10 pg DNA was prepared from calf thymus DNA and sample concentrations were calculated allowing for a linear conversion of log(fluorescence) to l o g (~g DNA).
Materials. PMA was purchased from Sigma, stored as a concentrated stock solution in DMSO, and diluted before use. N e tLeu-Phe (Sigma) was stored in stock solution of ethanol and diluted in buffer before use. Con A (Sigma) was prepared fresh before use.
RESULTS
Stimulation of MDM by a variety of stimuli elicits the assembly and activation of the NADPH oxidase, which catalyzes the reduction of oxygen to 02-, the respiratory burst (35) . We compared the respiratory burst activity of GSD I b and control MDM activated by Net-Leu-Phe and by Con A, both surface receptor-mediated agonists, and also by the phorbol ester PMA, which acts at a site distal to plasma membrane receptors, thereby bypassing part of the receptor-activated signaling pathway. As shown in Figure IA , stimulation of control MDM with either PMA, Wet-Leu-Phe, or Con A results in 02-production. Maximal 02-production was obtained with PMA (1.35 + 0.18 nmol 02-/pg DNA control MDM, mean + SEM, n = 4, which is equivalent to 12.7 nmol 02-/lo6 cells). This rate of PMAtriggered Oz-production in MDM is less than that of 0:-production in freshly isolated monocytes and neutrophils as previously reported (I 8, 19, 22-24) .
Wet-Leu-Phe M)-stimulation of GSD Ib MDM had significantly depressed Or-generation as compared with controls (0.25 + 0.05 nmol 02-/pg DNA GSD I b MDM vcrslrs 0.6 1 + 0.1 nmol 02-/pg DNA control MDM, n = 4, p < 0.02). This reduction in 02-production in GSD Ib MDM (42% of controls) was similar to the reduction in respiratory burst activity we reported in GSD I b monocyte suspensions (32% of controls, 11 = 3 patients) and neutrophils (1 7% of controls, 11 = 3 patients) (18, 19) . Defective generation of 01-was also observed in GSD with control short-term in vilro indicates that the defect is intrinsic and is not MDM cultured in the absence of IFN-y. IFN-y also increased a solely of in \'is0 host factors. Oz-production in G S D l b MDM stimulated with f M e t -~e u -~h e This study also demonstrates that the PMA-stimulated respi-(259%, p < 0.01), Con A (1700%, p < 0.0 I), or PMA (67%, p < ratory burst activity in GSD l b MDM is equivalent to that of 0.01) compared with GSD Ib MDM cultured with medium control~. Seger CJt a/. (10) observed normal NADPH-dependent alone (Fig. 1 B) . There was no significant difference between the 0 2 -production in neutro~hil lysates from a single GSD l b 02-generated by IFN-y-treated G S D I b MDM by PMA, m e t -patient, which is consistent with our observation. These results Leu-Phe, and Con A and their respective controls. Thus, in vilro suggest that the components that makc up the NADPH oxidase treatment of MDM with IFN-7 corrected the defective response are present in the cell and are fully functional. Thus, the GSD to fMet-Leu-Phe and Con A stimulation in MDM from GSD l b I b patient's phagocytic cell defect differs from chronic granupatients.
lomatous disease, which is distinguished by absent protein com- Figure 2 shows representative phase-contrast photomicro-ponents of the NADPH oxidase enzyme complex and in which graphs of MDM from control and G S D Ib patients cultured in long-term in viva therapy with IFN-y failed to improve the the presence or absence of I x lo5 U/L IFN-y. The control blunted respiratory burst (37) (38) (39) . cultured MDM demonstrated the morphologic changes that
The basis for the observation that PMA-stimulated 02-proaccompany maturation of monocytes into MDM (Fig. 28) : duction is defective in freshly isolated monocytes from GSD I b evidence of cytoplasmic spreading and increased cell diameter patients but not in rilro in MDM is not apparent but may be a (36) . In contrast, the GSD Ib M D M had smaller cell diameter result of alterations in the cellular environment. The presence of and less cytoplasmic spreading ( Fig. 2A) . GSD Ib MDM cultured an inhibitory factor or the absence of a growth factor in the in the presence of IFN-y responded with morphologic changes plasma of these patients may be responsible for the depressed similar to those of control cells cultured with IFN-y addition PMA-triggered OZ-production. Alternatively, monocyte adher- (Fig. 2 C and D) . Thus, the changes in respiratory burst activity ence and differentiation induces alterations in protein synthesis of the GSD Ib MDM upon 1FN-y treatment are paralleled by and cellular metabolism (22, 36) . This results in decreased resmorphologic changes.
piratory burst activity compared with peripheral blood mono- cytes and enhanced membrane depolarization and Ca" mobilization upon stimulation (21) (22) (23) (24) . Thus, cellular alterations induced by cell adherence or differentiation may restore the PMAstimulated respiratory burst upon GSD Ib monocyte maturation.
IFN-y addition during cell culture enhanced the respiratory burst activity in both control and GSD Ib MDM, thereby correcting the defective Met-Leu-Phe-and Con A-elicited respiratory burst activity in GSD Ib MDM. There are several different sites where IFN-y could alter respiratory activity in these patients' MDM; these include a direct effect on components of the NADPH oxidase enzyme complex, its assembly in the plasma membrane, or the signaling pathways that regulate the respiratory burst.
During monocyte maturation to macrophage, there is a downmodulation in the cells' ability to generate 0 2 - (23, 24) . This has been attributed to down-modulation of the mRNA for constituents of the NADPH oxidase, specifically the membrane-associated gp91 and the cytosolic p47 components (40, 41) . The culture of monocytes with IFN-y during maturation increases the expression of gp91 and p47, paralleling the increase in respiratory burst activity in these cells (40, 41) . In addition, IFN-y alters the signaling pathways involved in regulating respiratory burst activity, specifically modulation of intracellular Ca2+ levels. Incubation with IFN-y increased the free intracellular CaZ+ levels in human monocytes (42) and in the monocytic cell line U937 (43) . Furthermore, Ca2+ ionophores and phorbol esters, together, mimic the IFN-y-enhanced cytocidal activity in macrophages (44) . As stated previously, our results suggest that the respiratory burst defect is not due to decreased expression of the components of the NADPH oxidase itself. Thus, although up-regulation of gp91 and p47 after IFN-y treatment may be responsible for the overall increase in the potential rate of the respiratory burst, it is more likely that IFN-y corrects the respiratory burst defect in GSD Ib MDM by modulation of receptor expression and/or the signal transduction pathway through changes in intracellular Ca2+ levels.
The morphologic changes associated with IFN-y treatment of GSD Ib MDM suggests an IFN-y-mediated effect on signal transduction. GSD I b MDM did not show cytoplasmic spreading or morphologic alterations concomitant with monocyte differentiation unless cultured in the presence of IFN-y, which then resulted in morphologic changes similar to control cells. After adherence, a rise in intracellular Ca2+, similar to that in respiratory burst activity, is a necessary precedent to spreading in neutrophils (45) . We have previously demonstrated depressed Ca2+ mobilization in GSD Ib monocytes that is associated with decreased intracellular Ca2+ stores. This is suggestive of a common signaling defect affecting cytoplasmic spreading and respiratory burst activity in GSD Ib patients, possibly at the level of or before Ca2+ mobilization.
The mechanism(s) by which IFN-y corrects the deficient ligand-elicited respiratory burst in GSD Ib MDM remains to be elucidated. Defining the specific alteration(s) by which IFN-y normalizes the deficient respiratory burst activity in GSD l b MDM will provide further insight into the defect in GSD Ib respiratory burst activity. In summary, the 02-production in MDM from GSD I b patients was depressed in response to fMetLeu-Phe and Con A but not PMA stimulation. This selective defect in ligand-triggered 0 2 -generation can be corrected in vitro with IFN-y, which suggests that IFN-y should be considered for the treatment of this defect in patients with GSD 1b.
